NovaBay Pharmaceuticals, Inc. (NBY) SEC filings
NBY SEC filings moved a median of -2.24% by the close. NBY SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NBY overview →
102 measured NBY SEC filing events.
Where these NBY SEC filings landedvs 101 measured NBY SEC filing reactions
| Middle 50% of NBY SEC filing reactions | -7.57% to +3.30% |
|---|---|
| Median reaction (to close) | -2.24% |
| Measured reactions | 101 |
Point-in-time · zero look-ahead
Half of the 101 NBY SEC filing events with a measured close landed between -7.57% and +3.30%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Stablecoin Development For: Apr 06 | SEC filing · Form 8-K | — | — | |
| Form 8-K Stablecoin Development For: Mar 31 | SEC filing · Form 8-K | +1.14% | +23.42% | |
| Form 8-K NovaBay Pharmaceuticals, For: Mar 23 | SEC filing · Form 8-K | -1.68% | +15.97% | |
| Form 10-K NovaBay Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.92% | |
| Form 8-K NovaBay Pharmaceuticals, For: Mar 12 | SEC filing · Form 8-K | +0.00% | -2.42% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | -2.10% | +3.50% | |
| Form 8-K NovaBay Pharmaceuticals, For: Feb 20 | SEC filing · Form 8-K | -5.71% | -25.00% | |
| Form 8-K NovaBay Pharmaceuticals, For: Feb 11 | SEC filing · Form 8-K | +0.00% | -13.39% | |
| Form DEF 14A NovaBay Pharmaceuticals, For: Mar 12 | SEC filing · Form DEF | +8.00% | -2.76% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jan 30 | SEC filing · Form 8-K | -0.43% | -7.57% | |
| Form PRE 14A NovaBay Pharmaceuticals, For: Mar 12 | SEC filing · Form PRE | -0.43% | -7.57% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jan 22 | SEC filing · Form 8-K | -6.03% | -7.04% | |
| Form D NovaBay Pharmaceuticals, | SEC filing · Form D | -0.01% | +18.50% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jan 20 | SEC filing · Form 8-K | -11.83% | -40.85% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jan 16 | SEC filing · Form 8-K | -11.83% | -40.85% | |
| Form EFFECT NovaBay Pharmaceuticals, | SEC filing · Form EFFECT | -0.49% | +6.86% | |
| Form S-3/A NovaBay Pharmaceuticals, | SEC filing · Form S-3 | +0.00% | +8.49% | |
| Form S-8 NovaBay Pharmaceuticals, | SEC filing · Form S-8 | +0.00% | +8.49% | |
| Form 10-Q NovaBay Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -2.78% | +0.00% | |
| Form 8-K NovaBay Pharmaceuticals, For: Oct 16 | SEC filing · Form 8-K | +0.14% | +6.03% | |
| Form 8-K NovaBay Pharmaceuticals, For: Oct 20 | SEC filing · Form 8-K | +1.60% | -7.20% | |
| Form 8-K NovaBay Pharmaceuticals, For: Oct 16 | SEC filing · Form 8-K | +1.44% | +25.00% | |
| Form 8-K NovaBay Pharmaceuticals, For: Oct 09 | SEC filing · Form 8-K | +3.23% | -0.81% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +3.23% | -0.81% | |
| Form S-3 NovaBay Pharmaceuticals, | SEC filing · Form S-3 | -1.47% | -10.29% | |
| Form ARS NovaBay Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +2.86% | +2.86% | |
| Form DEF 14A NovaBay Pharmaceuticals, For: Oct 16 | SEC filing · Form DEF | +2.86% | +2.86% | |
| Form 8-K NovaBay Pharmaceuticals, For: Sep 18 | SEC filing · Form 8-K | +2.58% | -6.19% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +2.58% | -6.19% | |
| Form PRE 14A NovaBay Pharmaceuticals, For: Oct 16 | SEC filing · Form PRE | -0.74% | +24.05% | |
| Form 8-K NovaBay Pharmaceuticals, For: Aug 26 | SEC filing · Form 8-K | -5.02% | -14.84% | |
| Form 8-K NovaBay Pharmaceuticals, For: Aug 19 | SEC filing · Form 8-K | +6.42% | -5.50% | |
| Form 10-Q NovaBay Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.70% | +5.92% | |
| Form 10-Q NovaBay Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -0.56% | -1.84% | |
| Form 8-K NovaBay Pharmaceuticals, For: Apr 16 | SEC filing · Form 8-K | +0.00% | +0.02% | |
| Form 10-K NovaBay Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.35% | |
| Form NT 10-K NovaBay Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | +0.00% | +0.02% | |
| Form DEF 14A NovaBay Pharmaceuticals, For: Apr 16 | SEC filing · Form DEF | +0.00% | +2.48% | |
| Form 8-K NovaBay Pharmaceuticals, For: Mar 05 | SEC filing · Form 8-K | +0.00% | +7.63% | |
| Form 8-K NovaBay Pharmaceuticals, For: Mar 04 | SEC filing · Form 8-K | +0.00% | +7.14% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +7.14% | |
| Form PRE 14A NovaBay Pharmaceuticals, For: Apr 16 | SEC filing · Form PRE | +5.18% | -2.24% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jan 30 | SEC filing · Form 8-K | +6.08% | +9.03% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +6.08% | +9.03% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jan 16 | SEC filing · Form 8-K | -0.88% | -11.24% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | -0.88% | -11.24% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jan 15 | SEC filing · Form 8-K | -0.88% | -11.24% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jan 03 | SEC filing · Form 8-K | +4.57% | +11.68% | |
| Form 8-K NovaBay Pharmaceuticals, For: Dec 18 | SEC filing · Form 8-K | +0.00% | +1.84% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +0.68% | +5.07% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | -1.28% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +0.61% | |
| Form 8-K NovaBay Pharmaceuticals, For: Nov 22 | SEC filing · Form 8-K | -2.12% | -7.34% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | -3.68% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +2.42% | -0.08% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +0.98% | +7.62% | |
| Form 10-Q NovaBay Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.39% | -3.58% | |
| Form 8-K NovaBay Pharmaceuticals, For: Nov 05 | SEC filing · Form 8-K | -0.95% | -4.09% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | -0.95% | -4.09% | |
| Form 8-K NovaBay Pharmaceuticals, For: Oct 29 | SEC filing · Form 8-K | -2.86% | +3.30% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | -2.86% | +3.30% | |
| Form 8-K NovaBay Pharmaceuticals, For: Oct 16 | SEC filing · Form 8-K | +2.86% | +0.00% | |
| Form DEFM14A NovaBay Pharmaceuticals, | SEC filing · Form DEFM14A | +2.86% | +0.00% | |
| Form PREM14A NovaBay Pharmaceuticals, For: Nov 22 | SEC filing · Form PREM14A | +0.00% | +5.80% | |
| Form 8-K NovaBay Pharmaceuticals, For: Sep 19 | SEC filing · Form 8-K | -10.35% | -14.94% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | -10.35% | -14.94% | |
| Form 10-Q NovaBay Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -1.81% | -3.29% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jul 26 | SEC filing · Form 8-K | -2.44% | -7.42% | |
| Form EFFECT NovaBay Pharmaceuticals, | SEC filing · Form EFFECT | -1.22% | -13.56% | |
| Form POS EX NovaBay Pharmaceuticals, | SEC filing · Form POS | -4.51% | -11.88% | |
| Form S-1/A NovaBay Pharmaceuticals, | SEC filing · Form S-1 | -10.09% | -11.01% | |
| Form S-1/A NovaBay Pharmaceuticals, | SEC filing · Form S-1 | -1.07% | -7.30% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jul 11 | SEC filing · Form 8-K | +0.46% | +3.24% | |
| Form S-1/A NovaBay Pharmaceuticals, | SEC filing · Form S-1 | — | -7.02% | |
| Form D NovaBay Pharmaceuticals, | SEC filing · Form D | +0.45% | -0.90% | |
| Form EFFECT NovaBay Pharmaceuticals, | SEC filing · Form EFFECT | -2.90% | -8.30% | |
| Form S-1 NovaBay Pharmaceuticals, | SEC filing · Form S-1 | +0.94% | +0.47% | |
| Form S-8 NovaBay Pharmaceuticals, | SEC filing · Form S-8 | +0.94% | +0.47% | |
| Form S-1 NovaBay Pharmaceuticals, | SEC filing · Form S-1 | -0.85% | -6.55% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jun 14 | SEC filing · Form 8-K | +0.00% | +0.40% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jun 04 | SEC filing · Form 8-K | -2.63% | -9.67% | |
| Form 8-K NovaBay Pharmaceuticals, For: May 30 | SEC filing · Form 8-K | -1.45% | -8.43% | |
| Form 8-K/A NovaBay Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | -1.45% | -8.43% | |
| Form 8-K NovaBay Pharmaceuticals, For: May 28 | SEC filing · Form 8-K | -2.79% | +0.29% | |
| Form 10-Q NovaBay Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -3.00% | -7.16% | |
| Form 8-K NovaBay Pharmaceuticals, For: Apr 22 | SEC filing · Form 8-K | -3.48% | -12.96% | |
| Form 8-K NovaBay Pharmaceuticals, For: Apr 18 | SEC filing · Form 8-K | -3.48% | -12.96% | |
| Form ARS NovaBay Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.00% | +5.00% | |
| Form DEF 14A NovaBay Pharmaceuticals, For: May 28 | SEC filing · Form DEF | +0.00% | +5.00% | |
| Form DEFA14A NovaBay Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +5.00% | |
| Form PRE 14A NovaBay Pharmaceuticals, For: May 28 | SEC filing · Form PRE | -3.02% | -9.38% | |
| Form D NovaBay Pharmaceuticals, | SEC filing · Form D | -0.38% | -3.07% | |
| Form 10-K/A NovaBay Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.28% | -1.96% | |
| Form 10-K NovaBay Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -4.39% | -14.25% | |
| Form 8-K NovaBay Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | +0.00% | +5.94% | |
| Form 8-K NovaBay Pharmaceuticals, For: Mar 24 | SEC filing · Form 8-K | +0.00% | -3.88% | |
| Form 8-K NovaBay Pharmaceuticals, For: Mar 12 | SEC filing · Form 8-K | -6.53% | -10.20% | |
| Form 8-K NovaBay Pharmaceuticals, For: Jan 05 | SEC filing · Form 8-K | -3.16% | -9.17% | |
| Form D NovaBay Pharmaceuticals, | SEC filing · Form D | -0.23% | +1.79% | |
| Form 8-K NovaBay Pharmaceuticals, For: Dec 21 | SEC filing · Form 8-K | -5.21% | -11.27% | |
| Form 8-K NovaBay Pharmaceuticals, For: Dec 07 | SEC filing · Form 8-K | — | -2.85% | |
| Form 10-Q NovaBay Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.99% | -3.96% |
Keep exploring
More NBY: earnings → · analyst actions → · NBY overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | 206 | +0.02% | 51% |
| Curis, Inc. (CRIS) | 205 | 0.00% | 45% |
| OptiNose, Inc. (OPTN) | 205 | 0.00% | 48% |
| ASPEN PHARMACRE HL UN/ADR (APNHY) | 204 | 0.00% | 15% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.